EOS imaging's hipEOS receives FDA approval

Written by Anuja Vaidya | December 16, 2014 | Print  |

EOS imaging's hipEOS has received approval from the U.S. Food and Drug Administration.

hipEOS is a 3D hip arthroplasty planning software based on EOS' stereo-radiographic 2D/3D imaging. The software enables surgeons to perform pre-surgical planning including hip implant selection and virtual positioning in functional, weight-bearing 3D.


hipEOS received a CE Mark in March 2014 and will be launched in the U.S. in March next year.

More articles on devices:

The future of big orthopedic device companies: Boom or bust?
Stock report: 6 spine, orthopedic device company updates
MiMedx increases 2015 revenue projections by at least 50% — 5 key updates

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers